reported that inactivation of the COX-2 gene in the Apc knockout mouse, a model of human familial adenomatous Cyclooxygenase-2 (COX-2) is abundantly expressed in polyposis, or treatment of these mice with COX-2 selective colon cancer cells. It has been reported that inhibition inhibitors, dramatically reduces the size and number of intestof COX-2 enzyme activity is shown to prevent colon inal polyps (12). It is thus likely that increased expression of carcinogenesis. Thus, suppression of COX-2 expression COX-2 is an important contributor to colon tumor formation, may also be an effective chemopreventive strategy. In the and compounds that inhibit the activity and/or expression level present study, we constructed a β-galactosidase reporter of this enzyme are potentially of great interest as candidate gene system in human colon cancer DLD-1 cells, and chemopreventive agents against colon carcinogenesis. measured COX-2 promoter-dependent transcriptional Although major efforts have been made to develop selective activity in the cells. Interferon γ suppressed this COXinhibitors of COX-2 as chemopreventive agents against colon 2 promoter activity, while 12-O-tetradecanoylphorbol-13-cancer, efforts to identify agents that can selectively suppress acetate and transforming growth factor α (TGFα) exerted the expression of COX-2 at the gene level appear to be equally enhancing effects. We then tested the influence of 14 important. It is also likely that the combination of suppression candidate cancer chemopreventive compounds on COX-2 of COX-2 gene expression and selective inhibition of its promoter activity. Chemopreventive agents such as querceenzyme activity may provide the most effective approach tin, kaempferol, genistein, resveratrol and resorcinol, all to colon cancer prevention. Therefore, developing a simple having a common resorcin moiety, were found to effectively screening system, which could detect the suppression of suppress the COX-2 promoter activity with and without COX-2 gene expression, might be useful for searching novel TGFα-stimulation in DLD-1 cells.
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In the present study, we used a β-galactosidase (β-gal) resorcin-type structure may play an active role in the reporter gene system to estimate COX-2 promoter activity in inhibition of COX-2 expression in colon cancer cells.
human colon cancer cells. The human colon cancer cell line DLD-1 can be stably transfected with a construct harboring the promoter sequence of the COX-2 gene fused to the β-gal Introduction reporter gene. Using this β-gal reporter gene system, we Colorectal cancer is currently one of the major causes of death evaluated the effects of various cytokines and a tumor promoter, from cancer in developed countries and, thus the search for 12-O-tetradecanoylphorbol-13-acetate (TPA) on COX-2 prochemopreventive agents effective in the large bowel has moter activity, and also tested various potential chemoprevenbecome very important. Many epidemiological and experitive agents for their effects on COX-2 promoter activity. mental studies have demonstrated that inhibition of cyclooxygenase (COX) is an effective measure in reducing the risk Materials and methods of colon carcinogenesis (1,2). COX catalyzes the oxygenation Chemicals of arachidonic acid, leading to the formation of prostaglandins. Recently, the presence of two isoforms of COX has been Ascorbic acid, alpha-tocopherol, curcumin, epigallocatechin gallate, resveratrol, tannic acid, transforming growth factor α (TGFα) and TPA were obtained 
Cell culture
Abbreviations: β-gal, β-galactosidase; COX, cyclooxygenase; DHA, docosahexaenoic acid; FBS, fetal bovine serum; IFNγ, interferon γ; IL, interleukin; DLD-1 cells, a human colon adenocarcinoma cell line, were obtained from the Health Science Research Resources Bank (Osaka, Japan) and maintained MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NSAIDs, non-steroidal anti-inflammatory drugs; TGFα, transforming growth factor α;
in RPMI 1640 medium supplemented with 5% heat-inactivated fetal bovine serum (FBS; Hyclone Laboratories Inc., Logan, UT) and antibiotics (100 µg/ TPA, 12-O-tetradecanoylphorbol-13-acetate; PTKs, protein-tyrosine kinases. ml streptomycin and 100 U/ml penicillin) at 37°C in 5% CO 2 . Cells (2.0ϫ10 5 cells/ml) were plated in 96-well tissue culture plates and precultured for 24 h before treatment with test agents.
MTT assay
Cell viability in each culture was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. After treatment, the cells were further incubated in a medium containing 0.5 mg/ml of MTT for 1 h. The MTT formazan produced by living cells was dissolved in dimethyl sulfoxide and absorbance at 595 nm was measured on a microplate Reader (Bio-Rad Laboratories, Hercules, CA).
Reporter gene assay for COX-2 promoter-dependent transcriptional activity
Human genome DNA was isolated from peripheral lymphocytes obtained Fig. 1 . Effects of cytokines and TPA on COX-2 promoter activity in DLD-1 from a healthy volunteer. A 2078 nucleotide human COX-2 gene promoter cells. (A) Relative COX-2 promoter activity was measured after 48 h fragment stretching from -2046 to ϩ32 (relative to the transcription start treatment with TPA (200 ng/ml), IL-1β (10 ng/ml), TGFα (100 ng/ml) and site), containing all known transcription factor responsive elements and the IFNγ (10 ng/ml). The values presented are percentages of the unstimulated transcription start site of the gene (13), was amplified by PCR using a control culture value. (B) Suppression of COX-2 promoter activity by 48 h commercial PCR kit (Takara Shuzo Co., Otsu, Japan). PCR primers correspondtreatment with various doses (0.02-4.00 ng/ml) of IFNγ. Data are means Ϯ ing to sequences at the 5Ј end (forward primer, 5Ј-GGAACT-SE (n ϭ 3). Similar results were obtained from three separate experiments. CTTCACTCTATCCTGCTATATAAGGTGA-3Ј) and the 3Ј end (anti-sense primer, 5Ј-TCCTGACGCTCACTGCAAGTCGTATGACAATT-3Ј) of the 5Ј-flanking region, from -2046 to ϩ32, of the human COX-2 gene were synthesized by Sawady Technology Co. (Tokyo, Japan). The DNA fragment Table I . Compounds tested in this study was inserted into the upstream site of the lacZ gene of the pB2-βGal-BSD basic vector, which contains the lacZ gene and blasticidin-S deaminase (BSD)
Compound a Final dose gene. The resultant fusion plasmid was named pCOX2/B2-βGal-BSD. Glutathione (reduced form) 5000 The background β-gal activity was determined in control untreated culture of DLD-1/B2-βGal-BSD cells, and the value set as 0. The background β-gal a The underlined samples suppressed COX-2 promoter activity. activity was about the same as that in the non-transfected DLD-1 cells. Basal b Final dose tested in this study. β-gal activity of untreated DLD-1/COX2-B2-βGal-BSD was set as 100%.
c Compounds have a resorcin-type moiety as a common structure. The percent β-gal activity with each treatment was calculated from data for triplicate wells. The value was normalized for viable cell number, assessed by the MTT assay. All experiments were repeated at least three times with
Effects of chemopreventive agents on COX-2 promoter activity
nearly identical results. Data are expressed as means Ϯ SE (n ϭ 3).
The effects of the 14 compounds listed in Table I on TGFα-stimulated COX-2 promoter activity were examined. These Results compounds are known to have cancer chemopreventive properEffect of cytokines and TPA on COX-2 promoter activity ties and also have anti-oxidative properties. Among those, quercetin, kaempferol, genistein, resveratrol and resorcinol No significant difference was observed in the basal COX-2 promoter activity of DLD-1/COX2-B2-βGal-BSD cells significantly suppressed TGFα-stimulated COX-2 promoter activity in a dose-dependent manner, respectively (Figure 2 ). between serum-deprived cultures and 5% FBS-supplemented cultures after 48 h. To examine if the reporter gene assay was Decreases in TGFα-stimulated COX-2 promoter activity at the highest doses of test samples were as follows; 74% for 20 µM working correctly, cells were cultured in a medium containing 5% FBS, and the effects of TPA, IL-1β, TGFα and IFNγ on quercetin, 49% for 40 µM kaempferol, 79% for 40 µM genistein, 81% for 100 µM resveratrol and 53% for 500 COX-2 promoter activity were tested. Treatment of cells with 200 ng/ml TPA, 10 ng/ml IL-1β or 100 ng/ml TGFα for 48 h µM resorcinol (Figure 2A-E) . Thus, quercetin, genistein and resveratrol suppressed the TGFα-stimulated COX-2 promoter increased the activity to 1.8, 1.3 and 2.1 times the control value, respectively ( Figure 1A ). Treatment with 10 ng/ml IFNγ activity to below the basal level, but kaempferol and resorcinol did not. No response was seen in nine compounds listed in resulted in an 85% decrease of COX-2 promoter activity ( Figure 1A) . Dose-response studies showed that IFNγ at 0.02- Table I . For example, daidzein did not show any activity, even at the dose of 500 µM. 4.0 ng/ml suppressed COX-2 promoter activity in a dosedependent manner ( Figure 1B) . No significant decrease of cell Next, the effects of quercetin, kaempferol, genistein, resveratrol and resorcinol on COX-2 promoter activity in DLD-1 cells viability was observed after 48 h culture with IFNγ at these concentrations.
in the absence of TGFα were examined. These five compounds No significant decrease in cell viability was observed after 48 h culture with quercetin, kaempferol, genistein and resorcinol at the doses used in the experiments. However, resveratrol (72% cell viability in 25 µM concentration) reduced cell viability. Other compounds showed no significant suppressive effects on COX-2 promoter activity when used at the concentrations listed in Table I , and these doses gave~60% cell viability cytotoxicity.
Discussion
Since COX-2 is an interesting target for cancer chemoprevention, a reporter gene assay of COX-2 promoter activity in the human colon cancer cell line DLD-1 was used for screening of its suppressors in the present study. COX-2 promoter activity was detected in DLD-1 cells without stimulation, and this was clearly enhanced by TPA and TGFα, but suppressed by IFNγ, which was previously reported to reduce levels of COX-2 mRNA in airway epithelial cells (14) . Paradoxically, IFNγ is also known to be a strong stimulator of COX-2 expression in macrophages (15).
Using our reporter gene assay system, testing of 14 natural compounds known to have cancer chemopreventive activity showed quercetin, kaempferol, genistein, resveratrol and resorcinol to suppress both TGFα-stimulated and non-stimulated involved in their mechanisms of cancer prevention.
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